CORONA VACCINE: Who gets it first? Who pays?


CORONA VACCINE: Who gets it first? Who pays? Most countries are involved in research into developing a vaccine against corona virus infection (causing COVID-19). The vaccine is likely to be available soon (in a few months from now). However, there are many logistical challenges that need to be considered and planning done well in advanceContinue reading “CORONA VACCINE: Who gets it first? Who pays?”

OFATUMUMAB is MORE effective than TERIFLUNOMIDE in MULTIPLE SCLEROSIS


OFATUMUMAB is MORE EFFECTIVE than TERIFLUNOMIDE in MULTIPLE SCLEROSIS Multiple sclerosis (MS) is an autoimmune demyelinating disorder affecting optic nerves, brain and spinal cord. Treatment includes disease modifying treatments (DMTs) to reduce the number of relapses. In a recent study, ofatumumab was compared with teriflunomide in patients with relapsing remitting multiple sclerosis. Ofatumumab is anContinue reading “OFATUMUMAB is MORE effective than TERIFLUNOMIDE in MULTIPLE SCLEROSIS”

ANGIOEDEMA AFTER tissue PLASMINOGEN ACTIVATOR INFUSION


A 78-year old man presented with left hemiparesis of 90 minutes duration. A diagnosis of right MCA territory infarct was made and he was started on tissue plasminogen activator infusion for thrombolysis. 54 minutes after starting infusion, he developed swelling involving left side of tongue. t-PA infusion was stopped. A diagnosis of oro-lingual edema wasContinue reading “ANGIOEDEMA AFTER tissue PLASMINOGEN ACTIVATOR INFUSION”

Best Chance Against Corona is by Not Getting This Infection


Best Chance Against Corona is by Not Getting This Infection Dr Sudhir Kumar MD DM Corona Virus Disease- 2019 (COVID-19) is caused by a corona virus, named SARS CoV2. It started in China in late 2019 and has rapidly spread all over the world, including India. COVID-19 is highly contagious It is highly contagious andContinue reading “Best Chance Against Corona is by Not Getting This Infection”

BE CAUTIOUS WHILE USING HCQ FOR TREATING COVID-19 IN MYASTHENIA GRAVIS


BE CAUTIOUS WHILE USING HCQ FOR TREATING COVID-19 IN MYASTHENIA GRAVIS Hydroxychloroquine (HCQ) is anti-malarial drug, which is commonly used for treating rheumatological disorders such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). HCQ has been recommended for prophylaxis as well as treatment of COVID-19 infection. Myasthenia gravis (MG) is an autoimmune disorder resultingContinue reading “BE CAUTIOUS WHILE USING HCQ FOR TREATING COVID-19 IN MYASTHENIA GRAVIS”

YOGA AS ADD ON THERAPY IS SUPERIOR TO MEDICAL THERAPY ALONE IN MIGRAINE


Yoga as ADD-ON Therapy is Superior to Medical Therapy alone in Patients Suffering from Migraine Dr Sudhir Kumar MD DM Migraine is the commonest cause of headache, especially affecting young people, more common in women. Migraine leads to disability and is a leading cause of absence from work. The mainstay of migraine treatment is medicalContinue reading “YOGA AS ADD ON THERAPY IS SUPERIOR TO MEDICAL THERAPY ALONE IN MIGRAINE”

UNEXPECTED AND UNINTENDED BENEFITS OF LOCKDOWN


“UNEXPECTED & UNINTENDED BENEFITS” OF LOCKDOWN Dr Sudhir Kumar MD DM Apollo Hospitals, Hyderabad 25th May 2020 COVID-19 caused by SARS CoV2 virus is a pandemic that started from China and rapidly spread to about 200 countries worldwide. In the absence of a vaccine, strict lockdown was imposed in March 2020 to prevent a suddenContinue reading “UNEXPECTED AND UNINTENDED BENEFITS OF LOCKDOWN”

Olfactory Bulb Edema in a Patient with Loss of Smell due to COVID-19 infection


Loss of smell (anosmia) and loss of taste (dysgeusia) have been commonly noted in people with COVID-19 infection, including those without any other symptoms such as fever, cough or breathing difficulty. In a recent case, anosmia developed on day 7 of infection. MRI showed edema (swelling) and increased signal of olfactory bulbs and tracts. PatientContinue reading “Olfactory Bulb Edema in a Patient with Loss of Smell due to COVID-19 infection”

FACIAL PARALYSIS AS A NEUROLOGICAL MANIFESTATION OF COVID-19 INFECTION


About a third of COVID-19 patients have neurological manifestations. These include headache, dizziness, loss of smell, delirium, stroke, Guillain-Barre syndrome, meningitis and encephalopathy. Recently a case of facial paralysis was reported from Singapore (with a travel history from Spain). 27-year old man was admitted with myalgia, cough, headache and fever for 4 days. RT PCRContinue reading “FACIAL PARALYSIS AS A NEUROLOGICAL MANIFESTATION OF COVID-19 INFECTION”

SMOKING REDUCES THE RISK OF PARKINSON’S DISEASE (PD)


Smoking is a risk factor for many non-communicable diseases, such as heart attacks, strokes, cancers, chronic obstructive lung diseases, liver disease, diabetes and pneumonia. It is expected to cause 1 billion deaths in 21st century. However, it has one benefit. In a long term study, smokers were found to have lower occurrence of Parkinson’s diseaseContinue reading “SMOKING REDUCES THE RISK OF PARKINSON’S DISEASE (PD)”